GTCR-backed Cole-Parmer buys ZeptoMetrix

Cole-Parmer, which is backed by GTCR, has acquired Buffalo, New York-based ZeptoMetrix, a life sciences developer and manufacturer of quality control standards and verification panels used in molecular diagnostic testing for infectious diseases.

DealsHealthcareTMTBriefs